The American Society of Hematology (ASH) recently asked Jeffrey Lebensburger, D.O., Pediatric Hematology & Oncology, to serve on the committee to develop new clinical practice guidelines on sickle cell disease-related cardiopulmonary and kidney disease. The ASH anticipates that guideline development will launch in January 2017 and conclude with the publication of guidelines in spring 2019 in the journal, Blood. Congratulations to Dr. Lebensburger on this national leadership position! Dr. Lebensburger to Serve on ASH Guideline Panel
The American Society of Hematology (ASH) recently asked Jeffrey Lebensburger, D.O., Pediatric Hematology & Oncology, to serve on the committee to develop new clinical practice guidelines on sickle cell disease-related cardiopulmonary and kidney disease. The ASH anticipates that guideline development will launch in January 2017 and conclude with the publication of guidelines in spring 2019 in the journal, Blood. Congratulations to Dr. Lebensburger on this national leadership position!